All In Biotech

Drug Trial Radar · NCT05599815

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Last checked: Nov 19, 2026Latest source record: Apr 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jan 2023

Primary completion

May 2023

Study completion May 2023

Sponsor

Lead sponsor
Aldeyra Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Oct 31, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Conditions

  • Nephrotic Syndrome

Interventions

  • ADX-629Drug

    ADX-629 (250 milligrams) administered twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse Event (AE) QueryTime frame: From Day 1 to Day 90

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Amicis Research Center - Northridge

    Northridge, California

  • University of Colorado

    Aurora, Colorado

  • South Florida Research Institute

    Lauderdale Lakes, Florida

  • Emory University - Pediatric Nephrology

    Atlanta, Georgia

  • ClinCept, LLC

    Bremen, Georgia

  • Northwest Louisiana Nephrology

    Shreveport, Louisiana

  • Nevada Kidney Disease Hypertension Center (NKDHC)

    Las Vegas, Nevada

  • East Carolina University - Nephrology

    Greenville, North Carolina

  • The Ohio State University (OSU) Wexner Medical Center

    Columbus, Ohio

  • University of Toledo Medical Center

    Toledo, Ohio

  • Southern Utah Kidney and Hypertension Center

    St. George, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.